Abstract: Pre-exposure prophylaxis (PrEP) has the potential to help reduce new HIV infections among young men who have sex with men (YMSM). Using a cross-sectional survey of YMSM (N=1,507; ages 18-24), we gauged YMSM's PrEP awareness and PrEP-related beliefs regarding side effects, accessibility, and affordability. Overall, 27% of the sample had heard about PrEP; 1% reported ever using PrEP prior to sex. In a multivariate logistic regression, we found that YMSM were more likely to have heard about PrEP if they were older, more educated, were residentially unstable in the prior 30 days, had insurance, or reported having at least one sexually transmitted infection in their lifetime. We found no differences by race/ethnicity, history of i...
Background: Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention inter...
Objective: Men who have sex with men (MSM) are at high risk for HIV in Baltimore City. While pre-exp...
Introduction: HIV pre-exposure prophylaxis (PrEP) in the form of a daily oral medication is highly e...
Pre-exposure prophylaxis (PrEP) has been shown to prevent as many as 90% of HIV cases, yet it is not...
BackgroundRecent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV transmi...
Prevention is key to keeping men who have sex with men (MSM) protected from Human Immunodeficiency V...
IntroductionIntegrated knowledge regarding pre-exposure prophylaxis (PrEP) awareness and willingness...
Background: Men who have sex with men (MSM) continue to be disproportionately affected by HIV in Mal...
Background In 2014, the CDC issued guidelines recommending pre-exposure prophylaxis (PrEP) for peopl...
Background: Men who have sex with men (MSM) continue to be disproportionately affected by HIV in Mal...
BackgroundYoung men of color who have sex with men face a continual increase in rates of HIV infecti...
Background: Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (Truvad...
BACKGROUND: Inaccurate HIV risk perception by men who have sex with men is a barrier to HIV preventi...
The appropriate use of pre-exposure prophylaxis (PrEP) by men who have sex with men (MSM) can be hig...
INTRODUCTION: The uptake of pre-exposure prophylaxis (PrEP) against HIV is low among young men who h...
Background: Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention inter...
Objective: Men who have sex with men (MSM) are at high risk for HIV in Baltimore City. While pre-exp...
Introduction: HIV pre-exposure prophylaxis (PrEP) in the form of a daily oral medication is highly e...
Pre-exposure prophylaxis (PrEP) has been shown to prevent as many as 90% of HIV cases, yet it is not...
BackgroundRecent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV transmi...
Prevention is key to keeping men who have sex with men (MSM) protected from Human Immunodeficiency V...
IntroductionIntegrated knowledge regarding pre-exposure prophylaxis (PrEP) awareness and willingness...
Background: Men who have sex with men (MSM) continue to be disproportionately affected by HIV in Mal...
Background In 2014, the CDC issued guidelines recommending pre-exposure prophylaxis (PrEP) for peopl...
Background: Men who have sex with men (MSM) continue to be disproportionately affected by HIV in Mal...
BackgroundYoung men of color who have sex with men face a continual increase in rates of HIV infecti...
Background: Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (Truvad...
BACKGROUND: Inaccurate HIV risk perception by men who have sex with men is a barrier to HIV preventi...
The appropriate use of pre-exposure prophylaxis (PrEP) by men who have sex with men (MSM) can be hig...
INTRODUCTION: The uptake of pre-exposure prophylaxis (PrEP) against HIV is low among young men who h...
Background: Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention inter...
Objective: Men who have sex with men (MSM) are at high risk for HIV in Baltimore City. While pre-exp...
Introduction: HIV pre-exposure prophylaxis (PrEP) in the form of a daily oral medication is highly e...